GT Gain Therapeutics SA announced that Mr. Jeffrey Riley joined Gain Therapeutics as Independent Board Member. Mr. Riley has more than 25 years of experience in the biotechnology and pharmaceutical industries, during which he has negotiated numerous worldwide strategic corporate alliances, established joint ventures and assisted in venture financings to support product development. He has raised over $1.5 billion in equity and debt instruments. He has worked for big pharma (SmithKline Beecham and Pfizer), venture capital (Queensland Biocapital Fund /QIC) and numerous biotechnology companies in his capacity of business development and general management.